BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28820917)

  • 1. Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma.
    Sant DW; Tao W; Field MG; Pelaez D; Jin K; Capobianco A; Dubovy SR; Tse DT; Wang G
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO240-BIO246. PubMed ID: 28820917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational landscape of lacrimal gland carcinomas and implications for treatment.
    Bell D; Sniegowski MC; Wani K; Prieto V; Esmaeli B
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E724-E729. PubMed ID: 25899808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
    Xie M; Wei S; Wu X; Li X; You Y; He C
    Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing of adenoid cystic carcinoma.
    Stephens PJ; Davies HR; Mitani Y; Van Loo P; Shlien A; Tarpey PS; Papaemmanuil E; Cheverton A; Bignell GR; Butler AP; Gamble J; Gamble S; Hardy C; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; McLaren S; McBride DJ; Menzies A; Mudie L; Maddison M; Raine K; Nik-Zainal S; O'Meara S; Teague JW; Varela I; Wedge DC; Whitmore I; Lippman SM; McDermott U; Stratton MR; Campbell PJ; El-Naggar AK; Futreal PA
    J Clin Invest; 2013 Jul; 123(7):2965-8. PubMed ID: 23778141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
    Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
    Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT
    Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
    Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
    Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT2 identified as a potential target of mir-29a-3p via microRNA profiling of patients with high proliferation lacrimal gland adenoid cystic carcinoma.
    Zhao J; Liu X; Lin J; Jiang M; Xu F; Zhang C; Tang Q; Zhu L; Dong L; Lin T
    Exp Eye Res; 2022 Jun; 219():109067. PubMed ID: 35398208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
    Yu MD; Men CJ; Do H; Colevas AD; Lin JH; Egbert PR; Tse DT; Kossler AL
    Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e44-e47. PubMed ID: 34798653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.
    Costa PA; Tse DT; Benedetto P
    Oncologist; 2024 Mar; 29(3):263-269. PubMed ID: 38227581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
    J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells.
    Moeyersoms AHM; Gallo RA; Zhang MG; Stathias V; Maeng MM; Owens D; Abou Khzam R; Sayegh Y; Maza C; Dubovy SR; Tse DT; Pelaez D
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.
    Stoeck A; Lejnine S; Truong A; Pan L; Wang H; Zang C; Yuan J; Ware C; MacLean J; Garrett-Engele PW; Kluk M; Laskey J; Haines BB; Moskaluk C; Zawel L; Fawell S; Gilliland G; Zhang T; Kremer BE; Knoechel B; Bernstein BE; Pear WS; Liu XS; Aster JC; Sathyanarayanan S
    Cancer Discov; 2014 Oct; 4(10):1154-67. PubMed ID: 25104330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells.
    Ye Q; Ding SF; Wang ZA; Feng J; Tan WB
    Asian Pac J Cancer Prev; 2014; 15(12):4995-5000. PubMed ID: 24998577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
    Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
    Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic findings in seven lacrimal gland neoplasms.
    Hrynchak M; White V; Berean K; Horsman D
    Cancer Genet Cytogenet; 1994 Jul; 75(2):133-8. PubMed ID: 8055477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
    Lee SH; Jeong EG; Yoo NJ; Lee SH
    APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.